The Press Room

94.7 WCSX Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and member of the  Gynecologic Oncology Multidisciplinary Team  at Karmanos, educated Big Jim’s listeners about cervical cancer, how this cancer type is preventable with screening, clinical trials, and getting a second opinion at Karmanos within a week. Your browser does not support the audio element. Download Podcast

Karmanos Cancer Hospital, part of the Barbara Ann Karmanos Cancer Institute , has been named one of America’s Best Hospitals for Cancer Care in 2026 by the Women’s Choice Award ® , America’s trusted referral source for the best in health care. This recognition places Karmanos among the top-performing hospitals nationwide, ranking it in the top 2% of over 4,600 U.S. hospitals that offer cancer care services. This is the 13 th consecutive year Karmanos has been recognized by the Women’s Choice Award®...

WDIV Catching breast cancer early, before it spreads, gives patients better treatment options and outcomes. Hadeel Assad, M.D. , medical oncologist, co-leader of the  Breast Cancer Multidisciplinary Team  (MDT), member of the  Phase I Clinical Trials MDT , joined Local 4’s Live in the D to talk about breast cancer screening, advancements in treating breast cancer, clinical trials and why women should get a second opinion when they are diagnosed with breast cancer. Watch the interview here .

The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc , medical oncologist, to the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT). Dr. Choucair joins the team after completing his hematology and oncology clinical fellowship at Karmanos, where he served as chief fellow and worked closely with Karmanos oncologists and scientific researchers. He began seeing patients in July 2025 at Karmanos Cancer Center in Detroit and Karmanos Cancer Institute – Dearbo...

WSGW Pancreatic cancer is the third deadliest cancer in the U.S. There is no recommended screening for people at average risk, so it is important to understand the modifiable and non-modifiable factors, including conditions, genetic mutations and syndromes, that can lead to a higher risk of developing this disease. Wasif Saif, M.D., MBBS , medical oncologist and co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  at Karmanos, joined the Art Lewis Show to disc...

Patient Power A recent study presented at the American Society of Hematology (ASH) Annual Meeting compared treatment for CLL between academic centers and community cancer centers. Jay Yang, M.D. , hematologist, medical oncologist and leader of the  Hematology Oncology Multidisciplinary Team at Karmanos, commented on the study results, which showed that patients who received care at an academic center lived slightly longer. Dr. Yang also provided insight into a possible reason for the difference in ...

Patient Power Jailan Elayoubi, M.D. , medical oncologist and member of the  Breast Cancer , Phase I Clinical Trials and Sarcoma Oncology Multidisciplinary Teams at Karmanos, shared what patients can expect after their first chemotherapy treatment. She advised on what to do when feeling fatigued, when favorite foods start to taste disgusting, when patients should contact their oncologist, and more. Read the article here .

Patient Power Oncology massage could be beneficial to cancer patients; however, it may not be the answer for every cancer patient. Julia Magas, LMSW, supportive care oncology social worker, care manager and member of the Supportive Oncology Multidisciplinary Team at Karmanos, suggested whom patients should contact to determine if this type of massage is right for them and provided an online resource to help patients find an oncology massage therapist. Read the article here .

BlackDoctor.org Sometimes the diagnosis of small cell lung cancer (SCLC) is delayed. Amina Pervaiz, M.D. , pulmonologist and member of the  Thoracic Oncology Multidisciplinary Team (MDT), explained why SCLC can sometimes be missed in the early stages, and Khalil Choucair, M.D., MSc , medical oncologist and also a member of the Thoracic Oncology MDT, detailed what makes SCLC different from other lung cancers. Read the article here . Amina Pervaiz, M.D. Khalil Choucair, M.D., MSc

Prevention A new study finds that women who do not get their first mammogram as the guidelines indicate will continue to miss further screenings and have a 40% higher risk of dying from breast cancer. Eric Brown, M.D. , breast surgeon and co-leader of the Breast Cancer Multidisciplinary Team (MDT), and Alit Yousf, M.D., diagnostic radiologist, director of breast imaging and member of the Breast Cancer MDT at Karmanos, comment on the study and outline exactly when women should begin breast cancer screeni...